The Evernorth letter about Wegovy and Zepbound

In October 2026, Evernorth wrote to Episcopal Church Medical Trust members that GLP-1 coverage for weight loss ends January 1, 2027. What the letter says, what it leaves out and what to do before January.

In late October, members of the Episcopal Church Medical Trust received a letter headed “Coverage for GLP-1 Weight-Loss Medications Ending Effective January 1, 2027.” For many of us, it was the first we had heard of it. The letter isn’t posted online, so we quote it below from a member’s copy.

Who sent it

  • The letter comes from Evernorth Health Services and is dated October 2026. Members’ copies arrived on October 22, 2026. (Evernorth letter to members, October 2026)
  • Evernorth is Express Scripts’ parent company: “Express Scripts is Evernorth’s pharmacy benefit service.” (Express Scripts, Who we are) Express Scripts runs the pharmacy benefit for the Medical Trust’s plans that use the Anthem or Cigna network. (2027 Annual Enrollment Guide)
  • The decision is the Medical Trust’s. The letter says “the Medical Trust is changing its prescription drug coverage.” (Evernorth letter to members, October 2026) Who made it is on who decides what the Medical Trust covers.

What the letter says

All quotations are from the letter. (Evernorth letter to members, October 2026)

  • From January 1, 2027, GLP-1 medications for weight loss, “such as Wegovy and Zepbound,” will “no longer be covered under the prescription drug coverage plan.”
  • “These medications will be designated as excluded products and added to the Drug Exclusion List.”
  • “No prior authorization or medical necessity requests for GLP-1 medications for weight loss will be allowed or approved.”
  • “Medications on the Drug Exclusion List do not count towards annual deductibles or out-of-pocket costs.”
  • “The EncircleRx® program, including the requirement to participate in the Omada Prevention & Weight Health offering, will end on December 31, 2026.”
  • The reasons it gives are “Rising Costs” and “Responsible Stewardship of Plan Resources”: “Discontinuing coverage of GLP-1s for weight loss promotes the long-term sustainability of Medical Trust health plans while maintaining coverage for members who use these drugs to treat type 2 diabetes.”
  • It names two kinds of help: Digbi Health, which “does not prescribe medications,” and Quantum Health, which “can help you access GLP-1s at manufacturer direct-to-consumer pricing.” With Quantum, the member “will be responsible for the full cost of the medication.” More on each: Digbi Health and Quantum Health.

What the letter doesn’t say

  • It doesn’t mention a transition for people already in treatment. In August, asked whether members currently in treatment would lose coverage, the Church Pension Group’s (CPG’s) senior vice president for benefits policy and design answered: “Yes, they will. It’s for everybody. I hate to say there’s no grandfathering.” (Webinar recording, about 50:30, auto-captions)
  • It doesn’t name the other uses the FDA has approved: Wegovy for heart disease and MASH, Zepbound for sleep apnea. CPG has said it will “limit GLP-1 coverage to type 2 diabetes treatment,” and that “Members who use GLP-1s for a diagnosis other than diabetes will be responsible for the medications’ cost.” (CPG Connect, September 14, 2026) (Frequently asked questions)
  • It says “You will continue to have access to other covered weight-loss solutions,” and doesn’t list them. We have not found a list. Ask Quantum and your prescriber what remains covered.
  • It doesn’t say how late December refills are handled. Plans usually limit how much you can fill at once and how soon you can refill. (Help if you’re losing coverage)
  • It doesn’t say which members it applies to. CPG lists the change for “active employees and early retirees.” (CPG, Annual Enrollment) It does not appear to apply to retirees on Medicare: who is affected.

What to do next

  1. Talk with your prescriber before your current supply runs out, and make a plan for 2027. The practical steps, prices and what to be careful about are on Help if you’re losing coverage.
  2. Get answers about your own prescription in writing from Quantum Health, especially if you take one of these medicines for heart disease, sleep apnea or liver disease. The number and the questions to ask are on the support page.
  3. You can always file an internal appeal. The plan documents limit independent external review to denials “involving medical judgment” or, for prescriptions, “a decision based on medical information.” A plain exclusion usually does not qualify. (Can I appeal?; CPG health plan documents)
  4. Tell the Medical Trust what this means for you. CPG invites comments, questions and concerns about the changes; the addresses are on What you can do.

We understand why the Medical Trust acted. We ask it to keep members already in treatment covered for six to twelve months and to bring coverage back in 2028 in a form the plan can afford. Sign the letter, and see what we are asking for.

If something here is wrong, please tell us and we will correct it publicly.

Last updated

Back to top